| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |